Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease

Clinical Oral Investigations

Volumn 14, Issue 6, 2010, Pages 629-636

  Chen, Hui ^a   Zheng, Pei ^a   Zhu, Haihua ^a   Zhu, Jianhua ^a   Zhao, Lili ^a   El Mokhtari, Nour Eddine ^b   Eberhard, Jörg ^c   Lins, Markus ^b   Jepsen, Søren ^d  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Coronary heart disease; Oral inflammation; Periodontitis; Platelet activating factor; Systemic effects

Indexed keywords

AUTACOID; SULFIDE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; TOOTH PLAQUE;

ADULT; ALVEOLAR BONE LOSS; CORONARY DISEASE; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; PLATELET ACTIVATING FACTOR; SULFIDES; YOUNG ADULT;

EID: 78449236915     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-009-0346-5     Document Type: Article

References (46)

1. Wu LL (1999) Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 29: 127-133.
2. Mehta JL, Saldeen TG, Rand K (1998) Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31: 1217-1225.
3. Leinonen M, Saikku P (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2: 11-17.
4. Scannapieco FA, Genco RJ (1999) Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 34: 340-345.
5. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72: 1221-1227.
6. Geerts SO, Legrand V, Charpentier J, Albert A, Rompen EH (2004) Further evidence of the association between periodontal conditions and coronary artery disease. J Periodontol 75: 1274-1280.
7. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C (2004) Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 31: 25-29.
8. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436.
9. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445.
10. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40: 643-672.
11. Behrens TW, Goodwin JS (1990) Control of human T cell proliferation by platelet-activating factor. Int J Immunopharmacol 12: 175-184.
12. Denizot Y, Dupuis F, Praloran V (1994) Effects of platelet-activating factor on human T and B cells-an overview. Res Immunol 145: 109-116.
13. Ninio E (2005) Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr Opin Clin Nutr Metab Care 8: 123-131.
14. Ghesquiere SA, Hofker MH, de Winther MP (2005) The role of phospholipases in lipid modification and atherosclerosis. Cardiovasc Toxicol 5: 161-182.
15. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA (1999) Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ Res 85: 311-318.
16. Mueller HW, Haught CA, McNatt JM, Cui K, Gaskell SJ, Johnston DA, Willerson JT (1995) Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res 77: 54-63.
17. Cox CP, Wardlow ML, Jorgensen R, Farr RS (1981) The presence of platelet-activating factor (PAF) in normal human mixed saliva. J Immunol 127: 46-50.
18. Emingil G, Cinarcik S, Baylas H, Huseyinov A (2001) Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 72: 1032-1037.
19. Keles GC, Cetinkaya BO, Ayas B, Isildak I, Diraman E, Koprulu H, Acikgoz G (2007) Levels of gingival tissue platelet activating factor after conventional and regenerative periodontal surgery. Clin Oral Investig 11: 369-376.
20. Zheng P, Chen H, Shi S, Jepsen S, Eberhard J (2006) Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol 33: 797-802.
21. Zhou H, McCombs GB, Darby ML, Marinak K (2004) Sulphur by-product: the relationship between volatile sulphur compounds and dental plaque-induced gingivitis. J Contemp Dent Pract 5: 27-39.
22. Lamster IB, Oshrain RL, Celenti R, Levine K, Fine JB (1991) Correlation analysis for clinical and gingival crevicular fluid parameters at anatomically related gingival sites. J Clin Periodontol 18: 272-277.
23. Iacopino AM, Cutler CW (2000) Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71: 1375-1384.
24. Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim BO, Nares S, Iacopino AM (1999) Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol 70: 1429-1434.
25. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67: 1123-1137.
26. Arbes SJ Jr, Slade GD, Beck JD (1999) Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78: 1777-1782.
27. Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M (2000) Age, dental infections, and coronary heart disease. J Dent Res 79: 756-760.
28. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 1554-1560.
29. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R, Schreiber S (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113: 929-937.
30. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94: 874-877.
31. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733.
32. Berk BC, Weintraub WS, Alexander RW (1990) Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 65: 168-172.
33. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528-1534.
34. Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13: 93-100.
35. Montrucchio G, Alloatti G, Camussi G (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80: 1669-1699.
36. Montrucchio G, Camussi G, Tetta C, Emanuelli G, Orzan F, Libero L, Brusca A (1986) Intravascular release of platelet-activating factor during atrial pacing. Lancet 2: 293.
37. Miyaura S, Eguchi H, Johnston JM (1992) Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 70: 341-347.
38. Iatrou C, Moustakas G, Antonopoulou S, Demopoulos CA, Ziroyiannis P (1996) Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72: 611-616.
39. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83: 156-160.
40. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979.
41. Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM (1996) Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta 1301: 161-173.
42. Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13: 799-804.
43. Keles GC, Cetinkaya BO, Isildak I, Koprulu H, Acikgoz G (2006) Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy. J Periodontal Res 41: 513-518.
44. Rasch MS, Mealey BL, Prihoda TJ, Woodard DS, McManus LM (1995) The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J Periodontol 66: 613-623.
45. McManus LM, Marze BT, Schiess AV (1990) Deficiency of salivary PAF in edentulous individuals. J Periodontal Res 25: 347-351.
46. Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, Montaye M, Amouyel P, Ferrieres J, Ruidavets JB, Evans A, Bingham A, Ducimetiere P (2005) Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 34: 268-275.